65,437 trials
Substance Use Disorders
Primary: Percentage of Days of Alcohol or Substance Misuse in the Past 30 Days — 0.15; 0.16; 0.21; 0.16 % days misusing substances past 30 days
Language Development
Primary: Student Academic Vocabulary Knowledge in English — 9.36; 11.39 Number of correct responses — p=.003
Posttraumatic Stress Disorders
Primary: Change in Symptoms of Post-Traumatic Stress Disorder (PTSD) Between Baseline and Week 12 — -23; -20 units on a scale
Weight Gain · Weight Loss
Primary: Changes in the Mother's Body Weight Pre and Post Pregnancy — 2.39; 1.25; 1.37 kilograms
Multiple Myeloma
Primary: Part 1 - Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 6; 7; 4; 5 Participants
Colorectal Cancer · Metastatic Cancer
Primary: Objective Response — 1; 3; 2 Participants
Work-related Injury
Primary: Change in Work Hazard Exposure as Assessed by a Survey — -0.25; -0.07; -0.26 score on a scale
Congestive Heart Failure
Primary: Change in Quality of Life at 90 Days Post Enrollment — -4.2; -4.2; 0; -4.2 Scores on a scale (difference)
Cold Agglutinin Disease
Primary: Part A: Percentage of Participants With Response to Treatment — 72.7; 15.0 percentage of participants — p=<0.001
Anxiety Disorders · Panic Disorder · Agoraphobia
Primary: Panic Disorder Severity Scale — 6.72; 5.78; 7 score on a scale — p=>0.16
Alzheimer's Disease and Related Dementias
Primary: Neuropsychiatric Inventory Questionnaire Average Score During Hospital Admission — 5.36; 3.87 score on a scale
Epidermolysis Bullosa
Primary: Number of Patients Who Achieve at Least a 3-point Reduction in AI-NRS. — 1; 3 Participants — p=0.59
Heart Failure
Primary: Comparison of Reveal LINQ™ Subcutaneous Impedance (Units of Ohms) With Pulmonary Artery Pressure (Units of mmHg) From a Swan-Ganz Catheter During Right Heart…
SARS-CoV-2 Infection · COVID-19
Primary: Geometric Mean Titers (GMTs) of Full-Length S-Binding IgG Concentrations of Lyophilized Formulation SDVs and Frozen-Liquid Formulation in MDVs 1 Month After Dose 2…
Graft Versus Host Disease · Leukemia · Lymphoma
Primary: Relapse/Progression Rate at Two Years — 20 percentage of cumulative incidence